Skip to main content
. 2018 Mar 27;13(3):e0194082. doi: 10.1371/journal.pone.0194082

Fig 3. Effect of treatments on antiplatelets in rats.

Fig 3

A: Platelet aggregation induced by adenosine diphosphate and measured by turbidimetry, mean ± SD. N = 12. **p<0.01 vs. Sham. ##p<0.01 vs. Model. B, C: CD62p measured by flow cytometry, mean ± SD. N = 12. **p<0.01 vs. Sham. ##p<0.01 vs. Model. D: TXB2 and 6-keto-PGF1α levels in rat plasma, measured using a radioimmunoassay, mean ± SD. N = 12. *p<0.05, **p<0.01 vs. Sham; #p<0.05, ##p<0.01 vs. Model; ++p<0.01 vs. DAPT. E: TXB2/6-keto-PGF1α ratio, mean ± SD. N = 12. **p<0.01 vs. Sham; ##p<0.01 vs. Model; ++p<0.01 vs. DAPT.